FDA Import Refusal SCS-0813127-2/11/1 — SUPGRL Group Limited
The FDA refused shipment SCS-0813127-2/11/1 from SUPGRL Group Limited (Hong Kong) on Dec 6, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,333,75
Refusal details
- Date
- Dec 6, 2023
- Country
- Hong Kong
- Product Category
- Drugs and Biologics
- Product Code
- 66VBL99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,333,75